
Overview
Biocanto Pharma operates in the pharmaceutical sector and is part of the Investcare Pharmaceutical Group. For nearly three decades, it has supplied pharmacies with medicines, medical devices and dietary supplements, following storage standards for these products.
Financials
Revenue history (in k)
From the notes
| Profit allocation | No decision |
Filing timeliness
1 of 6 financial statements was filed late (for 2021, 27 days late).
- 202519/06/2026
- 202401/07/2025
- 202325/06/2024
- 202213/06/2023
- 202111/08/2022
- 202001/10/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Offer
- Effervescent tablets
- Nose and throat preparations
- Eye preparations
- Immune support preparations
- Probiotics
- Plasters and dressings
- Vitamins and minerals
Websites
- biocanto.plBiocantoWordPress 7.1ElementorGoogle AnalyticsGoogle Tag ManagerMeta PixelYoast SEOLLiteSpeed
Authorized Representatives
Manner of representation
In the case of a one-person management board, declarations of will on behalf of the company are made by the member of the management board. In the case of a management board consisting of two or more persons, the joint action of two members of the management board or of one member of the management board jointly with a commercial proxy is required to make declarations of will on behalf of the company.
Supervisory board
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 2,400 | $32,414.91 | 16.6667% | |
| 2,400 | $32,414.91 | 16.6667% | |
| 2,400 | $32,414.91 | 16.6667% | |
| 2,400 | $32,414.91 | 16.6667% | |
| 2,400 | $32,414.91 | 16.6667% | |
| 2,400 | $32,414.91 | 16.6667% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2025-01-01.
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Investcare S.A. | $1,437,633.79 | grupainvestcare.pl | ||
| Kleemed Pharmaceuticals Poland sp. z o.o. | $847,166.12 | kleemed.com.pl | ||
| Pharmnew sp. z o.o. | $651,236.76 | pharmnew.pl | ||
| Sincofarm sp. z o.o. | $407,150.59 | sincofarm.pl | ||
| Bonopharm sp. z o.o. | $405,123.74 | bonopharm.com | ||
| Ananta Medicare Poland sp. z o.o. | $203,111.90 | anantamedicare.pl | ||
| Kolpharma sp. z o.o. | $183,726.80 | kolpharma.pl | ||
| Pharmatonica sp. z o.o. | $172,500.36 | pharmatonica.pl | ||
| Toto Pharma Poland sp. z o.o. | $66,269.14 | totopharma.com | ||
| MB Pharma sp. z o.o. + limited partnership | $35,367.39 | mbpharma.pl |
Change history
| Date | Event | |
|---|---|---|
| 2025-04-04 | Share capital increase (17,000.00 PLN → 720,000.00 PLN) | |
| 2025-04-04 | Name change (Bielfarm → Biocanto Pharma) | |
| 2025-04-04 | Switch to PKD 2025 (9 PKD 2007 codes → 9 PKD 2025 codes) | |
| 2024-12-16 | Address change (Al. Niepodległości 106, 43-106, Tychy → Białobrzeska 45, 41-409, Mysłowice) | |
| 2023-09-28 | Share capital increase (5,000.00 PLN → 17,000.00 PLN) |
FAQ
Last updated: 2026-06-19
